findmyKOL

Kathleen Corey, MD

Basic profile

Massachusetts General Hospital

ORCID↗NPI↗
✓ Full record
RegionBoston, MA · NortheastSpecialtyGastroenterologyFocusGastroenterology
Active KOLfindmyKOL type: EliteLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH funding2008–2025

Kathleen Corey is a Gastroenterology physician affiliated with Massachusetts General Hospital. OpenAlex indexes 302 publications with 14,573 citations (h-index 59); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Gastroenterology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
302publications

Distinct works indexed by OpenAlex, matched via ORCID.

14,573citations

Total citations across indexed works.

59h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
9companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 2008–2025

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114

Telephone

617-724-6113

Registry record last updated 18 Jul 2012.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    89.4%
    Osmotic Laxative27.2%
    Gavilyte-G100%
    Part D≥38 patients
    Rifamycin Antibacterial17.9%
    Xifaxan100%
    Part D<11 patients

    + 3 more classes in this area

  • Cardiovascular

    10.6%
    Aldosterone antagonist (MRA)10.6%
    Spironolactone100%
    Part D<11 patients
Where care is delivered (Part B)77% facility · 23% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

5 NIH research awards on record, funded 2008–2025 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”